Header image

Session K: Addressing Gaps to Improve HCV Treatment Access

Tracks
.
Thursday, September 20, 2018
11:15 AM - 12:15 PM
Sala I

Speaker

Mrs Stine Nielsen
Epidemiologist
Freelance

Do National HCV Policies In The EU Address Treatment And Care For People Who Inject Drugs?

11:15 AM - 11:30 AM

Abstract

Speaker Presentation

Video Recording

Biography

Stine Nielsen works as a freelance epidemiologist for EMCDDA and other public organisations. She previously worked as an epidemiologist for WHO and the Robert Koch Institute.
Iuliia Makarenko
Phd Student
McGill University

Barriers And Facilitators Of Hepatitis C (HCV) Treatment Initiation Among People Who Inject Drugs In The Era Of New Direct Acting Antivirals

11:30 AM - 11:45 AM

Abstract

Speaker Presentation

Video Recording

Biography

Iuliia Makarenko's research interests include: Individual and contextual factors related to the transmission of HCV/HIV with a focus on the relationships between mental health problems and injection risk behaviors among people who inject drugs (PWID); and access to HCV care and treatment by PWID.
Agenda Item Image
A/Prof Graham Brown
Research And Evaluation Director
Centre For Social Impact, UNSW

W3 Framework: Understanding The Role And Quality Of Peer Led Programs By People Who Inject Drugs In A National Hepatitis C Response

11:45 AM - 12:00 PM

Abstract

Speaker Presentation

Video Recording

Biography

Dr Graham Brown is a senior research fellow at the Australian Research Centre in Sex, Health and Society, La Trobe University and he primarily works with community and peer led organisations focusing on building evidence for community driven responses to hepatitis C and HIV
Dr Jennifer Havens
Professor
University Of Kentucky College Of Medicine

Knowledge Around Direct Acting Antiviral Therapies And Willingness To Undergo HCV Treatment Among Rural Appalachian Opioid Users

12:00 PM - 12:05 PM

Abstract

Speaker Presentation

Video Recording

Biography

Dr. Jennifer Havens is an infectious diseases epidemiologist at the Center on Drug and Alcohol Research at the University of Kentucky. Her research interests include the infectious complications (HCV/HIV) of injection drug use in rural Appalachia. Dr. Havens has been following a cohort of rural opioid users since 2008.
Lasha Gulbiani
Researcher
Health Research Union

Attitude Of Staff Regarding Integrated Hepatitis C Treatment At Eight Harm Reducation Centers In Georgia

12:05 PM - 12:10 PM

Abstract

Speaker Presentation

Video Recording

Biography

Lasha Gulbiani received his bachelor's degree in public health at Tbilisi State Medical University (TSMU). Currently he is working at Health Research Union as epidemiologist and data manager. He is master's degree student at School of Public Health, TSMU. The topic of his thesis is HCV treatment outcome among PWID.
Dr Eithne Nic An Riogh
Intern
Mater Misericordiae University Hospital, Dublin

Integrating Hepatitis C Care For At-Risk Groups: Findings From A Multi-Centre Observational Study In Primary And Community Care

12:10 PM - 12:15 PM

Abstract

Speaker Presentation

Video Recording

Biography

Dr Eithne Nic an Riogh is recent graduate of Medicine, University College Dublin, Ireland. As a medical intern, Eithne is working in a research role with the HepCare Europe team at the Mater Misericordiae University Hospital, Dublin.

Chair

Tim Rhodes
Professor Of Sociology
University Of New South Wales

Tessa Windelinckx
Needle Exchange Coordinator Flanders
VZW Free Clinic

loading